These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2530019

  • 1. Prolonged decrease in blood pressure after atrial natriuretic peptide infusion in essential hypertension: a new anti-pressor mechanism?
    Singer DR, Markandu ND, Buckley MG, Miller MA, Sugden AL, Sagnella GA, MacGregor GA.
    Clin Sci (Lond); 1989 Sep; 77(3):253-8. PubMed ID: 2530019
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
    Singer DR, Markandu ND, Buckley MG, Miller MA, Sagnella GA, MacGregor GA.
    Hypertension; 1991 Dec; 18(6):798-804. PubMed ID: 1835959
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension.
    Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG.
    Hypertension; 2000 Oct; 36(4):588-93. PubMed ID: 11040240
    [Abstract] [Full Text] [Related]

  • 9. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
    Rocco S, Opocher G, Carpenè G, Mantero F.
    Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blood pressure and endocrine responses to changes in dietary sodium intake in cardiac transplant recipients. Implications for the control of sodium balance.
    Singer DR, Markandu ND, Buckley MG, Miller MA, Sagnella GA, Lachno DR, Cappuccio FP, Murday A, Yacoub MH, MacGregor GA.
    Circulation; 1994 Mar; 89(3):1153-9. PubMed ID: 8124802
    [Abstract] [Full Text] [Related]

  • 14. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
    Baldoncini R, Ferri C, Bellini C, Desideri G, De Angelis C, Santucci A.
    Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
    [Abstract] [Full Text] [Related]

  • 15. Plasma atrial natriuretic peptide, aldosterone, and plasma renin activity responses to gradual changes in dietary sodium intake.
    Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DR, MacGregor GA.
    Am J Hypertens; 1990 Nov; 3(11):863-5. PubMed ID: 2148092
    [Abstract] [Full Text] [Related]

  • 16. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
    Grandis DJ, Uretsky BF, Verbalis JG, Chong TK, Puschett JB.
    Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
    [Abstract] [Full Text] [Related]

  • 17. Hormonal and renal responses to atrial natriuretic peptide infusion in low-renin hypertension.
    Ferri C, Baldoncini R, Bellini C, Di Francesco L, Luparini RL, Cacciafesta, Santucci A.
    Am J Nephrol; 1995 Nov; 15(3):222-9. PubMed ID: 7618647
    [Abstract] [Full Text] [Related]

  • 18. Renal interaction of atrial natriuretic peptide with angiotensin II: glomerular and tubular effects.
    Rakugi H, Ogihara T, Nakamaru M, Saito H, Shima J, Sakaguchi K, Kumahara Y.
    Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):97-107. PubMed ID: 2523767
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.